TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens.

Michael A Leonard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.